QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2017     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord 期刊论文 Brain Research, 2017, 卷号: 1669, 页码: 97-105 作者:  Hou, Xinran;  Weng, Yingqi*;  Ouyang, Bihan;  Ding, Zhuofeng;  Song, Zongbin 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/03 BCP  bone cancer pain  TSA  trichostatin A  MOR  mu-opioid receptor  HDACs  histone deacetylases  HDACi  histone deacetylase inhibitors  PWMT  paw withdrawal mechanical threshold  PWTL  paw withdrawal thermal latency  Bone cancer pain  Mechanical hypersensitivity  Mu-opioid receptor  Histone deacetylase inhibitor  Trichostatin A   Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells 期刊论文 ONCOTARGETS AND THERAPY, 2017, 卷号: 10 作者:  Yang, Yang;  Yin, Wei;  Wu, Fengying;  Fan, Jiang 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 lung cancer  epigenetic inhibitor  azacitidine (5-AZA)  trichostatin A   Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo 期刊论文 ONCOLOGY LETTERS, 2017, 卷号: 13, 期号: 6, 页码: 4868-4874 作者:  Ma Junfen[1];  Li Nan[2];  Zhao Jimin[3];  Lu Jing[4];  Ma Yanqiu[5] 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/23 histone deacetylase inhibitor  trichostatin A  esophageal squamous cell carcinoma  oncolytic adenovirus